SRPT·803607100·US·equity·Healthcare - Biotechnology-13D/G
SRPT (SAREPTA THERAPEUTICS INC) is held by 165 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($321.1M), STATE STREET CORP ($143.9M), AQR CAPITAL MANAGEMENT LLC ($138.6M). Net institutional sentiment: Mixed.
See how SRPT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer